Picture of YARROW BIOSCIENCE logo

YARW — YARROW BIOSCIENCE News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Brief: VYNE Therapeutics Q3 Revenue USD 169 Thousand

Nov 06 (Reuters) - VYNE Therapeutics Q3 net income USD -7.28 million.

Q3 EPS from cont ops USD -0.17

Recent news on YARROW BIOSCIENCE

See all news